Health and Healthcare
24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)
Published:
Last Updated:
Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor.
The short interest in Amgen (AMGN) dropped 22% and Calgene (CELG) fell 20%.
Alexion Pharmaceuticals (ALXN) split its shares 2-for-1 stock.
The company’s stock has done well as this was in the mid-$70’s in mid-July and shares put in a new 52-week and multi-year high this week with shares briefly trading above $95.00.
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.